Skip to content
drillr.ai
Sign up

BBOT

BridgeBio Oncology Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.64
−2.37%
Ask drillr

  • Aug 11, 2026, 20:05 UTC

    BridgeBio Oncology Therapeutics reported financial results for the second quarter ended June 30, 2026, and provided a business update.

    Source: